RESEARCH TRIANGLE PARK, N.C.
Medicago opened its $32 million Vaccine Research and Production Facility in September of 2011. Located in Research Triangle Park, the 97,000-sf project will support commercial grade production of influenza vaccines using VLP (virus-like particle) plant-based manufacturing technology. The general contractor, KBR Building Group, was awarded a $19 million contract to build the facility in November of 2010. The plant can produce 10 million doses per month and can increase production within three months to respond to an influenza pandemic.
